Relief Therapeutics Holding AG is a Switzerland based drug development company focusing on clinical stage projects, primarily developing drugs of natural human origin. It is engaged in its operations for diabetic complications and respiratory diseases. The company is focused on developing drug candidates namely, Aviptadil and Atexakin alfa. Aviptadil is a biologically active endogenous human peptide that possesses anti-proliferative, anti-inflammatory, and immune regulatory activities. Atexakin alfa is a low dosage formulation of interleukin-6 that exhibits functions in diverse tissues and organs. The group operates its functions in Switzerland.

Related Companies

TickerCompanyChg %Mkt Cap
RLFTFRelief Therapeutics20.75%763.4M

Relief Therapeutics Company Questions & Answers

Q

How do I buy Relief Therapeutics (RLFTF) stock?

A

You can purchase shares of Relief Therapeutics (OTC: RLFTF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Relief Therapeutics's (RLFTF) main competitors?

A

There are no as such competitors for Relief Therapeutics.

Q

What is the target price for Relief Therapeutics?

A

There is no analysis for Relief Therapeutics

Q

How much is Relief Therapeutics (RLFTF) stock ?

A

The stock price for Relief Therapeutics (OTC: RLFTF) is $0.2264 last updated Fri May 07 2021 19:59:59 GMT+0000 (Coordinated Universal Time).

Q

When is the next Relief Therapeutics (RLFTF) dividend?

A

There are no upcoming dividends for Relief Therapeutics.

Q

When is Relief Therapeutics (OTC:RLFTF) reporting earnings?

A

There are no earnings for Relief Therapeutics

Q

When is the upcoming split for RLFTF?

A

There is no upcoming split for Relief Therapeutics.